Consistent with these findings, Nlrp3 gene silencing with or without FTZ blocked IL-1β production in HSCs (Figures 6(a) and 6(b)) and PA-induced steatosis (Figure 6(c)). The gene discussed is NLRP3; the disease is steatosis.